Here are sales figures for the third quarter for top-selling Pfizer prescription drugs:
PRODUCT NAME MAIN CONDITION/USE 3Q 2011 SALES 3Q 2010 SALES PERCENT CHANGE
Lipitor High cholesterol $2.6 billion $2.53 billion up 3 percent
Prevnar 13 Pneumococcal vaccine $1.01 billion $735 million up 37 percent
Enbrel (outside U.S.) Rheumatoid arthritis $957 million $799 million up 20 percent
Lyrica Fibromyalgia/pain $961 million $757 million up 27 percent
Celebrex Pain $643 million $578 million up 11 percent
Viagra Erectile dysfunction $493 million $459 million up 7 percent
Norvasc High blood pressure $350 million $330 million up 6 percent
Zyvox MRSA infections $321 million $285 million up 13 percent
Xalatan Glaucoma $277 million $416 million down 33 percent
Sutent Multiple cancers $298 million $257 million up 16 percent
Note: Sales changes include favorable benefit from currency exchange rates.
Source: Pfizer Inc.
BUT WE NEED MORE GUN LAWS? Judge Gives Strawman Seller Probation - Bearing Arms - Straw-Purchasing, Wisconsin
Kim Davis Should Have Done This | RedState
Charles Payne - Is it China or the World?
Arby’s apologizes to police department after employee refused to serve officer - Hot Air
Guy Benson - Hillary Spokesman on Email Server: Look, I Don't Know What 'Wiped' Means, Okay?
War on cops: Female officer in Penn. assaulted and thrown over guardrail after stopping to help disabled vehicle
How to Write a New York Times Op-Ed in Three Easy Steps | Human Events